Viewing Study NCT02214160


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-02-25 @ 10:04 PM
Study NCT ID: NCT02214160
Status: COMPLETED
Last Update Posted: 2023-08-01
First Post: 2014-08-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies
Sponsor: Ultragenyx Pharmaceutical Inc
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: UX007-CL202
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators